|
Name |
Tenellone H
|
Molecular Formula | C20H20O5 | |
IUPAC Name* |
2-hydroxy-6-[2-hydroxy-5-methyl-3-(3-methylbut-2-enoxy)benzoyl]benzaldehyde
|
|
SMILES |
CC1=CC(=C(C(=C1)OCC=C(C)C)O)C(=O)C2=C(C(=CC=C2)O)C=O
|
|
InChI |
InChI=1S/C20H20O5/c1-12(2)7-8-25-18-10-13(3)9-15(20(18)24)19(23)14-5-4-6-17(22)16(14)11-21/h4-7,9-11,22,24H,8H2,1-3H3
|
|
InChIKey |
VJAAWUIJTSNWHL-UHFFFAOYSA-N
|
|
Synonyms |
Tenellone H
|
|
CAS | NA | |
PubChem CID | 139590734 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 340.4 | ALogp: | 5.0 |
HBD: | 2 | HBA: | 5 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 83.8 | Aromatic Rings: | 2 |
Heavy Atoms: | 25 | QED Weighted: | 0.46 |
Caco-2 Permeability: | -4.706 | MDCK Permeability: | 0.00001630 |
Pgp-inhibitor: | 0.029 | Pgp-substrate: | 0.005 |
Human Intestinal Absorption (HIA): | 0.013 | 20% Bioavailability (F20%): | 0.43 |
30% Bioavailability (F30%): | 0.773 |
Blood-Brain-Barrier Penetration (BBB): | 0.048 | Plasma Protein Binding (PPB): | 99.43% |
Volume Distribution (VD): | 0.518 | Fu: | 0.90% |
CYP1A2-inhibitor: | 0.92 | CYP1A2-substrate: | 0.157 |
CYP2C19-inhibitor: | 0.833 | CYP2C19-substrate: | 0.064 |
CYP2C9-inhibitor: | 0.844 | CYP2C9-substrate: | 0.552 |
CYP2D6-inhibitor: | 0.764 | CYP2D6-substrate: | 0.273 |
CYP3A4-inhibitor: | 0.535 | CYP3A4-substrate: | 0.16 |
Clearance (CL): | 8.906 | Half-life (T1/2): | 0.333 |
hERG Blockers: | 0.014 | Human Hepatotoxicity (H-HT): | 0.675 |
Drug-inuced Liver Injury (DILI): | 0.327 | AMES Toxicity: | 0.78 |
Rat Oral Acute Toxicity: | 0.041 | Maximum Recommended Daily Dose: | 0.861 |
Skin Sensitization: | 0.474 | Carcinogencity: | 0.765 |
Eye Corrosion: | 0.007 | Eye Irritation: | 0.937 |
Respiratory Toxicity: | 0.501 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003863 | 0.452 | D0Y7PG | 0.312 | ||||
ENC003862 | 0.434 | D06BLQ | 0.301 | ||||
ENC004843 | 0.427 | D0H2ZW | 0.290 | ||||
ENC005677 | 0.427 | D0Y0JH | 0.287 | ||||
ENC004765 | 0.409 | D0N1FS | 0.270 | ||||
ENC002362 | 0.409 | D08QJS | 0.268 | ||||
ENC004238 | 0.406 | D00KRE | 0.267 | ||||
ENC004636 | 0.400 | D0Q0PR | 0.264 | ||||
ENC004233 | 0.390 | D0E6OC | 0.262 | ||||
ENC004817 | 0.369 | D06GCK | 0.257 |